Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Pharmacoeconomics|January 8, 1994
Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infectionS M Holliday, D FauldsDrugs|October 1, 1993
Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potentialS M Holliday, D FauldsPharmacoeconomics|February 6, 1998
Meropenem. A pharmacoeconomic review of its use in serious infectionsS M Holliday, P BenfieldDrugs|February 1, 1995
Venlafaxine. A review of its pharmacology and therapeutic potential in depressionS M Holliday, P BenfieldBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Interferon-beta-1a: A Review of its Pharmacological Properties and Therapeutic Potential in Multiple SclerosisS M Holliday, P BenfieldBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 1, 1997
Respiratory syncytial virus immune globulinS M Holliday, K L GoaDrugs & Aging|May 1, 1993
Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathyS M Holliday, G L PloskerDrugs|February 1, 1994
Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthmaS M Holliday, D Faulds, E M SorkinPharmacoeconomics|May 27, 1999
Fosphenytoin. Pharmacoeconomic implications of therapyS M Holliday, P Benfield, G L PloskerDrugs|March 1, 1993
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacyK J Palmer, S M Holliday, R N BrogdenPageof 1